Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. The Company's medicines are helping numerous patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.

Employee Rating

3.6More
TypePublic
HQNew York, US
Founded1887
Size (employees)23,700 (est)
Websitebms.com
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US
Report incorrect company information

Key People/Management at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chairman of the Board and Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, Chief Financial Officer and Global Business Operations
Paul Biondi

Paul Biondi

Senior Vice President, Strategy and Business Development
Adam Dubow

Adam Dubow

Senior Vice President, Chief Compliance and Ethics Officer
John Elicker

John Elicker

Senior Vice President, Corporate Affairs and Investor Relations
Ann Powell Judge

Ann Powell Judge

Senior Vice President, Chief Human Resources Officer
Show more

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in Zug, Rueil-Malmaison, Merseyside, Hanover and in 180 other locations
New York, US (HQ)
345 Park Avenue
Braine-l'Alleud, BE
4, Avenue de Finlande
Pudong Xinqu, CN
133 Fute N Rd
Rueil-Malmaison, FR
3 Rue Joseph Monier
Nagoya-shi, JP
12
Shinjuku-ku, JP
1
Show all (186)
Report incorrect company information

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Revenue

Embed Graph
Bristol-Myers Squibb's revenue was reported to be $20.78 b in FY, 2017
USD

Revenue (Q3, 2018)

5.7b

Gross profit (Q3, 2018)

4.0b

Gross profit margin (Q3, 2018), %

71%

Net income (Q3, 2018)

1.9b

Market capitalization (14-Nov-2018)

85.8b

Closing stock price (14-Nov-2018)

52.6

Cash (30-Sep-2018)

5.4b

EV

86.1b
Bristol-Myers Squibb's current market capitalization is $85.8 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

16.4b15.9b16.6b19.4b20.8b

Revenue growth, %

(3%)4%17%

Cost of goods sold

4.6b3.9b3.9b4.9b6.1b

Gross profit

11.8b11.9b12.7b14.5b14.7b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

4.1b3.8b3.9b3.9b4.0b4.2b4.1b4.4b4.9b4.9b4.9b5.1b5.3b5.2b5.7b5.7b

Cost of goods sold

1.2b968.0m991.0m1.0b847.0m1.0b1.1b1.1b1.2b1.3b1.3b1.6b1.6b1.6b1.6b1.6b

Gross profit

2.9b2.8b2.9b2.9b3.2b3.2b3.0b3.3b3.7b3.6b3.7b3.6b3.7b3.6b4.1b4.0b

Gross profit Margin, %

71%75%75%74%79%76%73%76%75%73%74%70%70%69%72%71%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.6b5.6b2.4b4.2b5.4b

Accounts Receivable

6.3b

Inventories

1.5b1.6b1.2b1.2b1.2b

Current Assets

18.9b14.6b10.4b13.7b14.9b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.6b2.0b1.6b4.5b975.0m

Inventories

(45.0m)(254.0m)97.0m(152.0m)(29.0m)

Accounts Payable

412.0m(44.0m)(919.0m)104.0m320.0m

Cash From Operating Activities

3.5b3.1b1.8b2.9b5.3b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

1.8b936.0m1.3b2.0b1.2b1.1b1.8b1.2b2.4b3.6b1.5b2.4b3.3b1.5b1.9b3.8b

Depreciation and Amortization

465.0m

Inventories

(8.0m)(144.0m)(157.0m)(162.0m)51.0m162.0m231.0m(44.0m)(111.0m)(107.0m)(71.0m)(58.0m)7.0m(4.0m)(122.0m)

Accounts Payable

301.0m(12.0m)(112.0m)63.0m(83.0m)(618.0m)(1.2b)(77.0m)(36.0m)(142.0m)(114.0m)(85.0m)63.0m(241.0m)(101.0m)(186.0m)
USDY, 2018

EV/CFO

24.5 x

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

2.5 x
Show all financial metrics

Bristol-Myers Squibb Operating Metrics

FY, 2015FY, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44
Show all operating metrics
Report incorrect company information

Bristol-Myers Squibb Online and Social Media Presence

Embed Graph
Report incorrect company information

Bristol-Myers Squibb Company Life and Culture

Report incorrect company information

Bristol-Myers Squibb Frequently Asked Questions

  • When was Bristol-Myers Squibb founded?

    Bristol-Myers Squibb was founded in 1887.

  • Who are Bristol-Myers Squibb key executives?

    Bristol-Myers Squibb's key executives are Giovanni Caforio, Charles Bancroft and Paul Biondi.

  • How many employees does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 23,700 employees.

  • What is Bristol-Myers Squibb revenue?

    Latest Bristol-Myers Squibb annual revenue is $20.8 b.

  • What is Bristol-Myers Squibb revenue per employee?

    Latest Bristol-Myers Squibb revenue per employee is $876.6 k.

  • Who are Bristol-Myers Squibb competitors?

    Competitors of Bristol-Myers Squibb include Johnson & Johnson, Novartis and Eli Lilly.

  • Where is Bristol-Myers Squibb headquarters?

    Bristol-Myers Squibb headquarters is located at 345 Park Avenue, New York.

  • Where are Bristol-Myers Squibb offices?

    Bristol-Myers Squibb has offices in Zug, Rueil-Malmaison, Merseyside, Hanover and in 180 other locations.

  • How many offices does Bristol-Myers Squibb have?

    Bristol-Myers Squibb has 186 offices.